Related Experiment Video

Updated: Jun 22, 2026

Identifying Protein-protein Interaction Sites Using Peptide Arrays
07:44

Identifying Protein-protein Interaction Sites Using Peptide Arrays

Published on: November 18, 2014

Novel genetic and peptide-based strategies targeting the Bcl-2 family, an update

Abdel Aouacheria1

  • 1Institut de Biologie et Chimie des Protéines, Lyon, France. a.aouacheria@ibcp.fr

Recent Patents on DNA & Gene Sequences
|June 13, 2009
PubMed

Insights

The Bcl-2 family regulates cell death by controlling mitochondrial permeability. Recent patents focus on developing peptide-based inhibitors targeting anti-apoptotic Bcl-2 proteins for cancer therapy.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Pharmacology

Background:

  • The Bcl-2 family of proteins is critical in regulating apoptosis by controlling mitochondrial membrane permeability.
  • Dysregulation of Bcl-2 family proteins is implicated in various human diseases, driving significant research interest.
  • Anti-apoptotic Bcl-2 proteins are key targets for developing novel anticancer therapeutics.

Purpose of the Study:

  • To review recent patent literature concerning Bcl-2 family proteins.
  • To highlight emerging strategies for therapeutic development targeting Bcl-2 family members.

Main Methods:

  • Review of recent patent publications related to Bcl-2 family proteins.
  • Analysis of therapeutic strategies involving nucleic-acid and peptide-based inhibitors.

Main Results:

  • Identification of recent patents focused on Bcl-2 family protein modulation.
  • Emerging strategies involve developing peptides or polypeptides derived from Bcl-2 family members.

Conclusions:

  • The Bcl-2 family remains a significant focus for therapeutic intervention, particularly in oncology.
  • Patent activity indicates a trend towards peptide-based approaches for targeting anti-apoptotic Bcl-2 proteins.

More Related Videos

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.